Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Oral Manifestations of Crohn's Disease: A Case Report and Review of the Literature.

Woo VL.

Case Rep Dent. 2015;2015:830472. doi: 10.1155/2015/830472. Epub 2015 Jul 9.

2.

Clinical predictors of thiopurine-related adverse events in Crohn's disease.

Moran GW, Dubeau MF, Kaplan GG, Yang H, Eksteen B, Ghosh S, Panaccione R.

World J Gastroenterol. 2015 Jul 7;21(25):7795-804. doi: 10.3748/wjg.v21.i25.7795.

3.

Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID).

Lee KM, Kim YS, Seo GS, Kim TO, Yang SK; IBD Study Group of the Korean Association for the Study of Intestinal Diseases.

Intest Res. 2015 Jul;13(3):193-207. doi: 10.5217/ir.2015.13.3.193. Epub 2015 Jun 9. Review.

4.

Optimizing the use of thiopurines in inflammatory bowel disease.

Goel RM, Blaker P, Mentzer A, Fong SC, Marinaki AM, Sanderson JD.

Ther Adv Chronic Dis. 2015 May;6(3):138-46. doi: 10.1177/2040622315579063. Review.

5.

Reactivity against microsatellite instability-induced frameshift mutations in patients with inflammatory bowel disease.

Kuehn F, Klar E, Bliemeister A, Linnebacher M.

World J Gastroenterol. 2015 Jan 7;21(1):221-8. doi: 10.3748/wjg.v21.i1.221.

6.

Therapeutic drug monitoring in inflammatory bowel disease.

Kopylov U, Ben-Horin S, Seidman E.

Ann Gastroenterol. 2014;27(4):304-312. Review.

7.

A phase II study of laquinimod in Crohn's disease.

D'Haens G, Sandborn WJ, Colombel JF, Rutgeerts P, Brown K, Barkay H, Sakov A, Haviv A, Feagan BG; Laquinimod for Crohn's Disease Investigators.

Gut. 2015 Aug;64(8):1227-35. doi: 10.1136/gutjnl-2014-307118. Epub 2014 Oct 3.

8.

Impact of medical therapy on patients with Crohn's disease requiring surgical resection.

Fu YT, Hong T, Round A, Bressler B.

World J Gastroenterol. 2014 Sep 7;20(33):11808-14. doi: 10.3748/wjg.v20.i33.11808.

9.

Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease.

Renna S, Cottone M, Orlando A.

World J Gastroenterol. 2014 Aug 7;20(29):9675-90. doi: 10.3748/wjg.v20.i29.9675. Review.

10.

Use of thiopurines in inflammatory bowel disease: Safety issues.

Konidari A, Matary WE.

World J Gastrointest Pharmacol Ther. 2014 May 6;5(2):63-76. doi: 10.4292/wjgpt.v5.i2.63. Review.

11.

Defining quality indicators for best-practice management of inflammatory bowel disease in Canada.

Nguyen GC, Devlin SM, Afif W, Bressler B, Gruchy SE, Kaplan GG, Oliveira L, Plamondon S, Seow CH, Williams C, Wong K, Yan BM, Jones J.

Can J Gastroenterol Hepatol. 2014 May;28(5):275-85. Review.

12.

A retrospective study showing maintenance treatment options for paediatric CD in the first year following diagnosis after induction of remission with EEN: supplemental enteral nutrition is better than nothing!

Duncan H, Buchanan E, Cardigan T, Garrick V, Curtis L, McGrogan P, Barclay A, Russell RK.

BMC Gastroenterol. 2014 Mar 20;14:50. doi: 10.1186/1471-230X-14-50.

13.

Medical management of crohn disease.

Scott FI, Osterman MT.

Clin Colon Rectal Surg. 2013 Jun;26(2):67-74. doi: 10.1055/s-0033-1348043. Review.

14.

Patterns of 6-mercaptopurine and azathioprine maintenance therapy among a cohort of commercially insured individuals diagnosed with Crohn's disease in the United States.

Lund JL, Cook SF, Allen JK, Carroll CF, Kappelman MD.

Clin Epidemiol. 2013 Dec 6;5:501-12. doi: 10.2147/CLEP.S51625. eCollection 2013.

15.
16.

Familial adenomatous polyposis and Crohn's disease in one patient: dilemmas and concerns.

Fidalgo C, Ferreira S, Rosa I, de Ferro SM, Pereira AD.

Case Rep Gastroenterol. 2013 Aug 24;7(2):358-62. doi: 10.1159/000354972. eCollection 2013.

17.

Thiopurines in inflammatory bowel disease revisited.

Bär F, Sina C, Fellermann K.

World J Gastroenterol. 2013 Mar 21;19(11):1699-706. doi: 10.3748/wjg.v19.i11.1699. Review.

18.

Methotrexate: underused and ignored?

Herfarth HH, Long MD, Isaacs KL.

Dig Dis. 2012;30 Suppl 3:112-8. doi: 10.1159/000342735. Epub 2013 Jan 3. Review.

19.

Current status of thiopurine analogues in the treatment in Crohn's disease.

Lakatos PL, Kiss LS.

World J Gastroenterol. 2011 Oct 21;17(39):4372-81. doi: 10.3748/wjg.v17.i39.4372. Review.

20.

Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease.

Bradford K, Shih DQ.

World J Gastroenterol. 2011 Oct 7;17(37):4166-73. doi: 10.3748/wjg.v17.i37.4166. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk